Most popular active substances contained in biosimilar drugs in Poland 2019
In the first half of 2019, most of the biosimilar drugs generating sales in Poland contained filgrastim, adalimumab, and infliximab.
You only have access to basic statistics.
This statistic is not included in your account.
Business Solutions including all features.
About the industry
About the region
Selected statistics
Other regions
Related statistics
Further related statistics